Sansure Biotech Inc. was founded in 2008 as a Sino-US joint venture with the goal of creating marketable in vitro diagnostics (IVD). With a comprehensive line of diagnostic reagents and analytical instruments, Sansure is able to develop custom-made solutions. Sansure's excellent U. S. Research and development facilities ensure that the company shall become a world leader in its respective patient groups. With unprecedented sensitivity and accuracy, Sansure has a phenomenal growth potential.

Sansure strives to become a global, broad-based healthcare company while making a difference in the lives of people around the world. The company operates under the strong quality management system of ISO 13485: 2003/ISO9001: 2008. Moreover, in order to address the needs and well-being of people in the safest possible manner, Sansure operates in accordance with the internationally recognized standards of the CE and FDA. Focusing on its expertise in molecular diagnostics, Sansure is committed to meeting the global demands which arise from addressing the needs of a diverse client base.